http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0036-46652018005000704&lng=en&nrm=iso&tlng=en

Rev. Inst. Med. trop. S. Paulo vol.60  São Paulo  2018  Epub Sep 13, 2018

http://dx.doi.org/10.1590/s1678-9946201860053

Letter to the Editor

Molecular detection of Borrelia burgdorferi in free-living golden headed lion tamarins (Leontopithecus chrysomelas) in Rio de Janeiro, Brazil

Aline Vieira Pinheiro dos Santos1  Aline Moreira de Souza1  Marina Galvão Bueno2  3  José Luiz Catao-Dias4  Helena Keiko Toma5  Alcides Pissinati4  6  Camila Vieira Molina2  Maria Cecília Martins Kierulff2  7  Danilo Gomes Freitas Silva2  4  Nádia Regina Pereira Almosny1 

 

Borreliosis is an infectious disease caused by Borrelia spirochetes, transmitted mainly by Ixodes ricinus ticks1 to animals or humans2. The known Borrelia species determine five distinct disease groups: human recurrent fever, avian borreliosis, bovine borreliosis, Lyme borreliosis and bovine scrapie3–6. Lyme disease (LD) is a multisystem disease with a wide geographical distribution and has B. burgdorferi as the main agent in several continents5,7.

In Brazil, borreliosis is called Brazilian Lyme-like disease, Baggio-Yoshinari Syndrome or Brazilian Borreliosis (BB), is transmitted by ticks that are not from the Ixodes ricinus complex, and is caused by B. burgdorferi sensu lato8.

Borrelia species were described in non-human primates that currently serve as an experimental model for Lyme disease2,9–11.

Borrelia species are transmitted primarily by ticks, but in rare cases or experimentally, they can be transmitted by tabanids, culicides and siphonapters12. Studies on borreliosis have been carried out to compare immunological, histopathological and clinical responses of animals and humans infected with Borrelia burgdorferi. In these studies, animals were inoculated or exposed to the Ixodides dammini tick1,9,11, and findings such as conjunctivitis, rash, deep perivascular lymphocytic infiltration that are characteristic in humans1, a large amount of spirochetes in nervous tissue of immunosuppressed animals9 and spirochetes in cardiac tissue10 were reported.

In order to identify arthropod-borne pathogens in an exotic invasive population of Leontopithecus chrysomelas (golden-headed lion tamarin), that inhabit Serra da Tiririca State Park (PESET), an urban Atlantic Rainforest area in Niteroi (Rio de Janeiro, Brazil), to translocate them to their native area (Bahia, Brazil), blood samples were analyzed. PESET harbor a large diversity of endemic fauna and flora and is considered an important ecotourism area. Inappropriate housing constructions, the increase of human and animal populations living inside the park or in its surroundings, hunting and inadequate garbage disposal have been recently causing damage to the park13.

This study was approved by the Ethics Commission on Animal Use (CEUA) from Universidade Federal Fluminense (process N° 367, issued in 10/10/2013) and was in full compliance with the federal authorizations issued by the Environment Ministry (SISBIO n 30939-4 issued in 18/05/2012). All procedures were also approved by the Committee on Ethics on Animal Research (CEUA) of Veterinary Medicine and Animal Science Faculty of the Universidade de Sao Paulo (Protocol N° 2662/2012 and 7085041215).

Blood samples of 200 L. chrysomelas, males and females, of different ages and independent of clinical alterations were subjected to DNA extraction using the Illustra blood genomic Prep Mini Spin Kit (GE Healthcare Life Sciences, Sao Paulo, Brazil), according to the manufacturer instructions. Extracted DNA was then used as the template DNA in B. burgdorferi sensu lato (s.l.) amplifications. Nested Polymerase Chain Reaction (n-PCR) assay using primer 5Bor-out (5′-GTCAAACGGGATGTAGCAA TAC-3′) and 3Bor-out (5′-CACACTTAACACGTTAGCTTCG-3′), followed by a second reaction with primer 5Bor-in (5′-ATTCAGTGGCGAACGGGTG-3′) and 3Bor-in (5′-AACAACGCTCGCCCCTTAC-3′), which amplifies a fragment of 811 bp/ 469 bp of the 16S rRNA gene of B. burgdorferi sensu lato, were performed.

A total of 16% (32/200) L. chrysomelas were positive to B. burgdorferi by n-PCR. Sequencing of five positive samples showed 99% of similarity with B. burgdorferi sequences available in GenBank. This was the first time that borreliosis is found in non- human primates in Brazil.

Borrelia infection in humans was first described in Brazil in 1992, and has an increasing number of suspect cases, differing from LD due to the recurrence rate after treatment and the intense immune response8. The presence of Borrelia burgdorferi in free-living golden-headed lion tamarins that inhabit Atlantic Forest biome of Rio de Janeiro, Brazil, confirms that this spirochete is circulating in this region and suggests that these small primates may play a role in transmission of this pathogen to other animals or human beings. Veterinarians and medical doctors should consider this zoonotic pathogen in their diagnostic routine.

Further studies are needed, including sequencing of all positive samples, in order to compare these small primates positive sequences with those of humans and other animals in study area.

REFERENCES

1. Philipp MT, Aydintug MK, Bohm RP Jr, Cogswell FB, Dennis VA, Lanners HN, et al. Early and early disseminated phases of Lyme disease in the rhesus monkey: a model for infection in humans. Infect Immun. 1993;61:3047-59. [ Links ]

2. Soares CO, Ishikawa MM, Fonseca AH, Yoshinari NH. Borrelioses, agentes e vetores. Pesq Vet Bras. 2000;20:1-19. [ Links ]

3. Babour AG, Hayes SF. Biology of Borrelia species. Microbiol Rev. 1986;50:381-400. [ Links ]

4. Quinn PJ, Carter ME, Markey BK, Carter GR. Clinical veterinary microbiology. London: Wolfe; 1994. [ Links ]

5. Wang G, van Dam AP, Le Fleche A, Postic D, Peter O, Baranton G, et al. Genetic and phenotypic analysis of Borrelia valaisiana sp. nov. (Borrelia genomic groups VS116 and M19). Int J Syst Bacteriol. 1997;47:926-32. [ Links ]

6. Zingg BC, LeFebvre RB. Polymerase chain reaction for detection of Borrelia coriaceae, putative agent of epizootic bovine abortion. Am J Vet Res. 1994;55:1509-15. [ Links ]

7. Bennett CE. Ticks and Lyme diseases. Adv Parasitol. 1995;36:343-405. [ Links ]

8. Basile RC, Yoshinari NH, Mantovani E, Bonoldi VN, Macoris DG, Queiroz-Neto A. Brazilian borreliosis with special emphasis on humans and horses. Braz J Microbiol. 2017;48:167-72. [ Links ]

9. Cadavid D, O’Neill T, Schaefer H, Pachner R. Localization of Borrelia burgdorferi in the nervous system and other organs in a nonhuman primate model of Lyme disease. Lab Invest. 2000;80:1043-54. [ Links ]

10. Cadavid D, Bai Y, Hodzic E, Narayan K, Barthold SW, Pachner AR. Cardiac involvement in non-human primates infected with the Lyme disease spirochete Borrelia burgdorferi. Lab Invest. 2004;84:1439-50. [ Links ]

11. Roberts ED, Bohm RP Jr, Lowrie RC, Habicht G, Katona L, Piesman J, et al. Pathogenesis of Lyme neuroborreliosis in the rhesus monkey: the early disseminated and chronic phases of disease in the peripheral nervous system. J Infect Dis. 1998;178:722-32. [ Links ]

12. Alvim NC, Bento MA, Martins LA. Borreliose de Lyme: a doença da década. Rev Cient Eletr Med Vet. 2005;4. [ Links ]

13. Instituto Estadual do Ambiente. Resumo executivo: plano de manejo: Parque Estadual da Serra da Tiririca – PESET. Rio de Janeiro: INEA; 2012. [ Links ]

Received: August 13, 2018; Accepted: August 16, 2018

 

http://nationalpainreport.com/thc-vs-cbd-for-pain-the-differences-and-interactions-by-winston-peki-8837164.html

THC vs. CBD for Pain: The Differences and Interactions

 

As a natural pain-relief drug, some experts consider cannabis more suitable for your body than the synthetic pharmaceuticals available.

The reasoning behind this is that the body can metabolize natural chemicals better than synthetic ones the same way it can digest natural foods better than processed ones.

Synthetic drugs, as with processed food, can create by-products, which remain as harmful toxins in the body, causing strain on the liver and kidneys. Some (medical) strains of cannabis also provide many health benefits, such as anti-oxidant, anti-depressant, anti-anxiety, pain-suppression, and anti-inflammatory effects.

Not only studies, but many users strongly support the pain-relieving properties of medical marijuana in anecdotal reports. Different types of strains, however, suit different pain conditions, so before diving into medical marijuana use, it’s important to understand the differences.

Let’s look at the difference between the strains of marijuana available, and what their effects are. With the information below, you can hopefully make an informed choice about whether it’s better to use a high-THC or high-CBD strain for your pain relief.

A Brief Overview of THC and CBD

Cannabinoids are the active ingredients specific to the cannabis plant, and they are the compounds primarily responsible for the healing effects. The two most effective and studied cannabinoids are tetrahydrocannabinol (THC) and cannabidiol (CBD).

There have been 70 cannabinoids identified to date, and there are several others currently being studied, such as cannabigerol (CBG) and tetrahydrocannabivarin (THCV).

They are not the only active ingredients, however, and some estimates predict a figure of over 120 active components in the plant. This richness in active compounds is one of the reasons experts consider it useful for treating several ailments.

It is worth noting that THC and CBD also only convert to an effective pain-relieving agent under heat, which is why smoking, vaporizing, or baking it is important.

Most cannabis oils and extracts, designed for direct consumption, haven’t undergone heat treatment. Without heat before ingestion, their effects may not manifest.

The Difference Between THC and CBD

Both THC and CBD contribute to the positive effects associated with marijuana. However, experts only link THC to the strong psychoactive effect known as getting high. This is one of the primary differences between the two components.

The Predominant Effects of High-THC Strains

THC is the primary psychotropic component in marijuana, that is the component responsible for an altered state of mood and perception. This effect makes THC attractive to recreational users.

But THC also contains strong anti-inflammatory and analgesic properties, so it has shown some success in the treatment of pain caused by inflammation, such as arthritis, and cancer.

THC relaxes the nervous system, which helps in spasm-related pain, such as multiple sclerosis. The altered mental state caused by THC can contribute to relieving severe pain in some cases in the same way medicine uses opiates to treat pain.

The Predominant Effects of High-CBD Strains

CBD has received recognition for its anti-carcinogenic qualities. Alongside the lack of feeling “high,” CBD has shown positive anti-inflammatory and pain relief effects. Clinical trials have proven links to suppressing pain receptors from some of the chemical reactions caused by CBD.

CBD has powerful anti-oxidant properties, which also help to support the immune system. Although not considered psychoactive, it can help with the depression, and anxiety sometimes a side-effect of chronic pain.

Cannabidiol Oil and Medical Supplements

Natural cannabis oil supplements are available in capsule and spray forms, as well as oils, which patients can smoke or consume orally. Patients should not confuse medical supplements with the synthetic pharmaceutical varieties, which mimic the effect of cannabis but are not natural. Medical supplements can be pure THC, pure CBD or, so called ‘full-spectrum products’ like CBD oil, which contain ALL the beneficial compounds found in the hemp plant.

The Effects of THC versus CBD in Pain Relief

More clinical trials have linked CBD to positive results for pain relief than THC.

For example:

Chronic Pain. A 2017 report concluded that there was substantial evidence that hih-CBD cannabis-based products are effective for treating chronic pain. Another, separate study published in 2012 in the Journal of Experimental Medicine, suggests that CBD use can lessen both pain and inflammation.

Digestive Pain. CBD has proven it also can help immensely as a digestive aid and digestive pain as well. Researchers have found evidence, as suggested in Cannabinoids for treating inflammatory bowel diseases: where are we and where do we go? that the endocannabinoid system, digestion and CBD have all sorts of interactions. While research involving CBD to treat digestive issues is still in its early beginnings, the experts believe it has the potential to help with all sorts of digestive issues which often come with pain.

Arthritis Pain. Arthritis, which literally means inflammation of the joints, is another condition that CBD oil may be very effective for. Research published in 2016 in the European Journal of Pain found a dramatic reduction in inflammation and signs of pain, without adverse side effects in rats with arthritis after the animals were given a topical gel that contained CBD for four days.

While some studies have shown positive effects of THC on pain relief, particularly for cancer-related pain, the side effects, like altered mental states, make it a less preferred cannabinoid to CBD. Although THC is more effective in muscle-spasm-related pain.

Interactions Between THC and CBD

When looking to reduce your pain, you don’t have to make a choice between THC and CBD. In fact, it could be wise to combine the two. Researchers have found that cannabis really is a synergistic shotgun in the sense that all the compounds in the cannabis plant interact with each other.

Although the exact mechanisms for these interactions remain unclear, the most effective cannabis-based pain treatments have been found to contain a combination of both THC and CBD. So, if your laws and regulations allow, go for a cannabis-based product which contains both compounds in good amounts. Just realize that THC can produce altered mental states, which can be dangerous while doing things that require proper hand-eye coordination like driving.

Choosing a Strain

There are a large range of chemical compositions within the high-THC and high-CBD varieties of cannabis. These can produce different medical effects.

To complicate the matter, the same product can have vastly different results in different people.

When looking for a natural herbal form of cannabis, the sativa strain (cannabis sativa) generally has a higher amount of CBD, whereas the indica strain (cannabis indica) contains more THC. However, due to crossbreeding this is not always reliable. Anecdotal evidence suggests that sativa is more energizing whereas indica is more of a relaxant. This observation may explain some differences that are not specific to the THC or CBD content and why many people prefer indica for pain relief. If you want therapeutic amounts of CBD, always go for a high-CBD strain, this can either be Sativa or Indica.

Conclusion

In medical use for pain relief, doctors prefer the CBD varieties of cannabis extract over THC, primarily due to their lack of side effects. Supplements combining CBD and THC, such as Sativix, have shown the best results in adults in clinical trials. Although experts prefer CBD because it has no side-effects, combining both CBD and THC might be the most effective way to treat pain.

Medical marijuana has fewer risks than other pain-relief medications such as codeine. It also offers more benefit while providing similar pain-relief effects. Since the reactions are incredibly variable and risks of any adverse effect are very low, it is best to discuss options for your pain management with a medical professional and begin with a small dose as a trial. Select the most suitable option for your needs, and let the results quickly manifest themselves.

Winston Peki is a marijuana enthusiast and vaporizer expert. Born and raised in Amsterdam He is the Founder of Herbonaut, an informative vaporizer and cannabis-based products site where you can find vaporizer reviews, CBD oil reviews and more.

_________________

More on CBD derived from marijuana:  

https://madisonarealymesupportgroup.com/2018/06/14/caffeine-more-dangerous-than-cannabis/

https://madisonarealymesupportgroup.com/2015/05/19/marijuana-the-miracle-herb/

 

 

 

https://doi.org/10.2147/IJGM.S176493 https://doi.org/10.2147/IJGM.S176493

Relapsing fever Borrelia in California: a pilot serological study

Middelveen MJ, Shah JS, Fesler MC, Stricker RB.

International Journal of General Medicine 2018 Sep 21;11:373-382. eCollection 2018.

Abstract

Background

Borrelia spirochetes are tick-borne Gram-negative bacteria that cause disease in humans and animals. Although many studies have focused on Borrelia burgdorferi (Bb), the agent of Lyme disease, recent studies have examined the role of Relapsing Fever Borrelia (RFB) in human disease. In this pilot study, we have evaluated serological reactivity against Bb and RFB in patients residing in California.

Methods

Serological testing for reactivity to Bb and RFB antigens was performed in 543 patients with suspected tick-borne illness using a Western blot technique. Further evaluation of a subset of 321 patients residing in California was obtained. Serum samples were tested for IgM and IgG antibodies reactive with Bb and RFB, and samples were classified by county of residence according to Bb reactivity alone, RFB reactivity alone, and dual reactivity against Bb and RFB. Seroreactivity was ranked in counties with the highest absolute number and the highest prevalence of positive samples.

Results

Of the 543 total serum samples, 32% were positive for Bb, 22% were positive for RFB, and 7% were positive for both Bb and RFB. Of the 321 serum samples from patients residing in California, 33% were positive for Bb, 27% were positive for RFB, and 11% were positive for both Bb and RFB. In the California cohort, the highest rates of positive serological testing for Bb were found in Santa Clara, Alameda, and Contra Costa counties, while the highest rates of positive serological testing for RFB were found in Santa Clara, Alameda, Marin, and San Francisco counties. The highest rates of dual reactivity against Bb and RFB were found in Contra Costa, Alameda, and San Francisco counties. Among the 24 counties with patients who were tested, Bb seropositivity alone was found in four counties, RFB seropositivity alone was found in two counties, and seropositivity for both Bb and RFB was found in 14 counties.

Conclusion

Results of this pilot study suggest that seroreactivity against Bb and RFB is widespread in California, and dual exposure to Bb and RFB may complicate the diagnosis of tick-borne disease. Greater awareness of RFB and broader screening for this tick-borne infection is warranted.

__________________

**Comment**

Recently it was discovered that that new relapsing fever like genomes have links to the Lyme disease borrelia.  Guess patients haven’t been making this up after all:  https://madisonarealymesupportgroup.com/2018/10/04/new-relapsing-fever-like-genomes-found-with-links-to-lyme-disease-borrelia/

California patients, similarly to Southern patients, have been told for decades they can’t have Lyme, because it doesn’t exist in their neck of the woods.

That was baloney then and it’s baloney now.
Time to start listening to patients who have far better things to do than fake illness.

https://www.lymedisease.org/relapsing-fever-calif/  (Video abstract of research article in link)  This article states that Relapsing Fever Borrelia (RFB) was thought to only be in Europe and the East Coast of the U.S.  This again demonstrates patients who are complaining of “Lyme-like” symptoms are truly infected with tick borne pathogens of one sort or another.  The one-drug, one-pathogen paradigm does not work with these patients.  Approved FDA testing BTW, doesn’t even exist for RFB.

“A negative Lyme test does not rule out the possibility of infection with Relapsing Fever Borrelia, and clinicians should be familiar with disease presentation and available diagnostic tests.”  Melissa Fesler, nurse practitioner

“Tick-borne Relapsing Fever is the next wave of Lyme disease,” says Stricker. “It’s not just a simple disease anymore.”

This again, demonstrates the importance of being educated on ALL TBI’s, and understanding that ALL TBI diagnosis is clinical.  Testing is abysmal.

For more on California and tick borne illness:  https://madisonarealymesupportgroup.com/2018/06/23/say-what-california-fifth-in-nation-for-lyme-insurance-claims/

https://madisonarealymesupportgroup.com/2018/05/19/infected-ticks-in-california-its-complicated/

https://madisonarealymesupportgroup.com/2017/08/07/california-lyme-cases-get-no-respect/

https://madisonarealymesupportgroup.com/2018/02/02/miyamotoi-in-ixodes-pacificus-in-california/

https://madisonarealymesupportgroup.com/2018/02/15/b-miyamotoi-in-ca-ticks-for-a-long-time/

https://madisonarealymesupportgroup.com/2018/02/14/borrelia-miyamotoi-in-ca-serodiagnosis-is-complicated-by-multiple-endemic-borrelia-species/

https://madisonarealymesupportgroup.com/2017/10/09/bb-in-california-chipmunk-and-squirrels/

https://madisonarealymesupportgroup.com/2011/09/25/putting-lyme-behind-you-questions-and-answers-with-california-lyme-doctors/

For interested practitioners on HOW to become educated:  https://madisonarealymesupportgroup.com/2018/06/06/lyme-education-for-healthcare-professionals/

 

http://www.greenmedinfo.com/blog/vaccine-safety-and-efficacy-studies-are-bases-marketing-authorizations-are-comple

Vaccine Safety and Efficacy Studies That are the Bases for Marketing Authorizations are a Complete Methodological Mess

“Vaccines are held to the highest standard of safety. The United States currently has the safest, most effective vaccine supply in history. Vaccines undergo a rigorous and extensive evaluation program to determine safety and effectiveness.” (U.S. Department of Health & Human Services. https://www.vaccines.gov/basics/safety/informed/. accessed on 28 January 2017)

Claims that vaccines “undergo rigorous and extensive testing”, that they are “held to the highest standard of safety”, etc., are lies. The sad truth is exactly the opposite. The studies that are the bases for marketing authorizations are a complete and utter methodological mess. They are designed so very badly that they do not allow the detection and evaluation of short-term, let alone long-term vaccination effects. Such methodologically so inadequate studies should never be part of the process of granting marketing authorizations. I have to emphasize here that the mass utilization of untested vaccines, i.e. vaccines that haven’t been reliably tested, isn’t rare. On the contrary, granting a marketing authorization to vaccines without methodologically sound studies of safety and efficacy is a rule, not an exception.

“The design of a study, the procedures used and the very execution of a project are the elements which determine to a great extent the quality of scientific work and the (in)validity of its results. Poor research design and methodology lead to lack of credibility of findings and, in case of medicinal products, to a potentially erroneous evaluation of efficiency, safety and profitability of the pharmaceutical preparation. The entire scientific research process, from planning to publication, is subject to a string of identified and well described mistakes, distortions and partiality. The latter can be an unintended consequence of poor mastering of the research process or lack of experience. Proneness to error, which is intrinsic to scientific work, also opens the door to deliberate and well thought exploitation of this possibility with the intention to manipulate” (Gajski 2009, p. 66).

If we summarize all that is wrong with the majority of safety and immunogenicity studies, including the ones submitted in the process of gaining a marketing approval, we get a truly chilling picture: instead of rigorous scientific studies in the true sense of the word, we have studies that are methodological mess. Studies that are, obviously intentionally[1], designed so poorly that they would be barely fit for a college assignment, if that. They are designed in such a way that they cannot reveal the actual safety and efficacy profile of individual vaccine, they do not allow for any reliable and correct evaluation of vaccines. Consequently, despite claims about “rigorous scientific studies”, millions of children are routinely injected with untested vaccines whose true safety and efficacy profiles remain largely unknown.

Below I briefly summarized the most common and typical methodological “flaws”.

1. Preclinical safety studies are often not done. And if they are done, they are so poorly designed and limited in their scope, that they are almost useless. However, preclinical (animal)[2] studies are of immense importance; they are the only way to truly research vaccines’ side effects and should form an integral and unavoidable part of any registration process.

It is true that animal studies have their own set of problems (for example, it is often difficult to find an adequate animal model, results cannot be 100% applied to humans, etc.) but they do allow:

  • invasive and frequent examinations and tests,
  • autopsy,
  • longitudinal studies (over 3 generations or more).

Those are the three most important aspects. Researchers should sincerely and actively search for all kinds of side effects, including theoretical/hypothetical ones. Instead, they are actively shutting their eyes and looking the other way. Many injuries, abnormalities, pathologies, etc. can only be revealed by a proper autopsy, so this should form an integral part of every study. And in many instances, with each passing generation, effects (both good and bad) of certain substance become more pronounced, wider in scope and higher in intensity. To discover the true range of possible side effects, one has to look not only for long term effects as such (for example, effects that become apparent in few months or years), but also research how it would affect the third, fourth, fifth generation[3].

2. Pharmacokinetic studies are not required for vaccines. They aren’t required for any vaccine component, not even for adjuvants (EMA, 17 May 2005, p. 4; WHO, 17–21 November 2003, p. 14). Consequently, such studies – i.e. studies of the time course of drug absorption, distribution, metabolism, and excretion – aren’t done. In other words, vaccines are granted a marketing authorization without a single study about how their components act in the body, how are they absorbed, how and where are they transported, how they affect various organs, where are they deposited, how are they excreted, etc.

Of course, the lack of preclinical safety studies and pharmacokinetic studies is not the only problem. Tomljenovic and Shaw (2011a, 2630) stated that “to the best of our knowledge, no adequate studies have been conducted to assess the safety of simultaneous administration of different vaccines to young children. Another issue of concern is the lack of any toxicological evaluation about concomitant administration of aluminum with other known toxic compounds which are routine constituents of commercial vaccine preparations, e.g., formaldehyde, formalin, mercury, phenoxyethanol, phenol, sodium borate, polysorbate 80, glutaraldehyde. In spite of all this, aluminum adjuvants are generally regarded as safe and some researchers have even recommended that no further research efforts should be spent on this topic despite a lack of good-quality evidence […] to the best of our knowledge, no adequate clinical studies have been conducted to establish the safety of concomitant administration of two experimentally-established neurotoxins, aluminum and mercury, the latter in the form of ethyl mercury (thimerosal) in infants and children”.

3. Observation period is extremely short, often only 5–15 days after each vaccine dose and rarely more than 30 days. Such study cannot detect any medium- and long-term side effects. On the basis of a few weeks’ observation, vaccines are declared “safe” and pumped into millions of children worldwide.

4. Placebo (saline solution) is practically never used. Instead either an older version of a vaccine, a vaccine from different manufacturer or a vaccine’s solution without antigens (but with all the other substances, including aluminum) plays a role of “placebo.” Such studies are then shamelessly and manipulatively called “placebo-controlled.” All this despite the fact that adjuvants cause a large percentage of serious side effects (aluminum adjuvants, for example, cross the blood-brain barrier and more or less permanently lodge in brains, where they can cause inflammation, swelling, demyelination, etc.).

This strategy enables researchers (and producers, and institutions, and all the other players in this sordid story) to literally state that “the new vaccine is as safe as placebo” or that “the rate of side effects was comparable to those from placebo”. In this way they can relatively successfully camouflage the true (high) rate of side effects. This is again a nice example of “how to lie without actually telling a lie.”

This problem was also pointed out by Tomljenovic and Shaw (2011a, 2630–2632): “…for the purpose of evaluating safety and efficacy, vaccine clinical trials often use an aluminum-containing placebo, either containing the same or greater amount of aluminum as the test vaccine. Without exception, these trials report a comparable rate of adverse reactions between the placebo and the vaccine group (for example, 63.7% vs. 65.3% of systemic events and 1.7% vs. 1.8% of serious adverse events respectively). According to the U.S. Food and Drug Administration (FDA), a placebo is ‘an inactive pill, liquid, or powder that has no treatment value’. The well-established neurotoxic properties of aluminium therefore suggest that aluminum cannot constitute as a valid placebo. […] While direct application of aluminum adjuvants to the central nervous system (CNS) is unquestionably neurotoxic, little is known about aluminum transport into and out of the CNS, its toxicokinetics, and the impact on different neuronal subpopulations following subcutaneous or intramuscular injections. The reason for this is that under current regulatory policies, evaluation of pharmacokinetic properties is not required for vaccines. This issue is of special concern in context to worldwide mass immunization practices involving children whose nervous systems are undergoing rapid development. Furthermore, an immature developing blood brain barrier (BBB) is more permeable to toxic substances than that of an adult. In addition, there are critical periods in neurodevelopment that occur within first few years of postnatal life during which exposure to neurotoxic insults may induce central nervous system (CNS) damage. In that respect, it is worth noting that any potential CNS damage caused by aluminum in children may not be evident until a later stage of development”.

5. Since there is no true placebo, there is also no true control group. Vaccinated children are never compared to unvaccinated ones. Especially not to truly unvaccinated ones (i.e. to children that have never received any vaccine). Supposedly, it would be terribly unethical if a group of study children would receive a true placebo and remain unvaccinated for at least a few months. However, it is perfectly “ethical and rational” to inject millions of children with multiple doses of vaccines whose safety has never been tested. It is “ethical and rational” to vaccinate children with these untested vaccine, loaded with neurotoxins, while they are still developing, while their immune and nervous system are still very vulnerable.

6. Side effects are literally observed. There are no blood tests, no neurological examinations[4] or any other adequate examinations. Only fever and swelling at the injection site are measured. Everything else is simply “observed”. By parents, who report their observations on diary cards. It is truly ironical that parental observations are accepted in the course of the study, yet are ridiculed, disregarded and negated in all other situations (like, for example, when concerned parents return to their doctor and report about child’s changed behavior, screaming, regression). Even when study children exhibit clear symptoms of potential neurological injuries (like high-pitched crying, irritability, somnolence, etc.), they are not properly examined. And as a rule, almost all reactions, especially the more serious ones, are “believed to be unrelated to the vaccine”.

7. Majority of clinical trials is financed by producers[5]. And in the process of granting a marketing approval, all studies are financed and conducted by the producer. It would be very naive to think that this does not affects trial results. Independent research is scarce these days, but still, it “has repeatedly warned that drug companies may manipulate clinical trial designs and subsequent data analysis and reporting to make their drugs look better and safer […] Keeping in mind that ‘the primary interest of a pharmaceutical company is developing and selling pharmaceutical product’, one must ask whether rational vaccine policy decisions should be based on conclusions derived from an uncritical acceptance of flawed vaccine safety and efficacy estimates provided by the vaccine manufacturer” (Tomljenovic and Shaw 2012d, p. e13).

8. Study reports are often too incomplete. But, as pointed out by Gajski (2009, pp. 66–67), “the methodology and design of clinical trials can only be judged on the basis of trial reports. Even though there are rules of reporting, methodology is often described poorly and incompletely, with important data and, in particular, side effects’ reports missing. Manipulation with procedures and data in scientific research is a well-known phenomenon. Excluding a few persons from the sample or adding a singular event can already ensure statistical reliability and produce the desired results. In fact, even complete forgeries can find their way through the filter of the most prestigious journals, as shown by a study published in The Lancet journal in 2005. The study demonstrated beneficial effects of anti-inflammatory drugs on the incidence of the oral cavity cancer. However, later it was proven that the author simply made up the study, the patients and the course of their disease”.

In order to obtain at least an approximately reliable and realistic evaluation of a vaccine’s properties and actions, every study or summary thereof (including summaries of medicinal products’ characteristics) should contain at least the following information:

  • time and place of the performance of the study;
  • individual stages of the study with a detailed description of the design and course (including the timeline) of every stage;
  • the number of persons included in each stage and their characteristics (age, health condition, etc.), the size and characteristics of each category of the persons involved;
  • inclusion and exclusion criteria;
  • reasons for withdrawal from the study and the number of persons who withdrew from every individual stage;
  • detailed description of the executed procedures, e.g. in case of side effects, an accurate description of how long after each dose of vaccine the side effects were observed and recorded and how (whether they were only recorded and reported on cards by parents or whether any tests were performed – blood or neurological tests, magnetic resonance, etc.; if so, what were the results);
  • the vaccination regime, what was used as placebo, the constituents of all applied substances, including the placebo;
  • detailed description of the implemented protocols according to individual stages, including definitions of terms and criteria and explanations of deviations;
  • a detailed numerical representation of all results, including all partial results according to individual stages and categories of participants.

9. Only healthy children are included in trials. While this is a rational choice (also from the methodological point of view) the problem is that in reality, practically all children are vaccinated or are supposed to be vaccinated, including the ones with existing neurological or immunological disorders, autoimmune diseases, etc[6]. All these conditions can be caused by vaccination; if a child already suffers from one of them (either due to previous vaccinations or due to other causes) it is highly probable that vaccination would seriously aggravate his condition.

10. Vaccine is declared effective on the basis of its ability to induce the production of antibodies. However, the presence of antibodies does not equal protection, immunity, efficacy. Vaccine might even be completely ineffective, despite its ability to induce the production of antibodies. Thus, adequate[7] animal studies in which both vaccinated and unvaccinated (control) animals would be exposed to infectious agents should be mandatory part of registration process. Instead, such studies are practically never conducted, much less submitted in the registration process.

You can find a detailed and in-depth analysis of studies that were submitted in the process of granting the marketing authorization for some of the vaccines (e.g. Infanrix, M-M-R II, M-M-RVaxPro, HBVaxPro, Procomvax, Recombivax-HB) in my book Ideological Constructs of Vaccination.


The book Ideological Constructs of Vaccination addresses, in evidence-based detail, the shakiness, dubiousness, often even falseness of the most common, self-evident and deeply rooted claims about vaccines – about their safety, efficacy, rigorous testing and regulation, etc. – thus depicting a disturbing image of states’ and scientific institutions’ operation. It is based on the author’s doctoral thesis with the same title.

In the first part, the author, Dr. Mateja Cernic, points out the socio-political aspects of vaccination, from the legal regulation of vaccination to discourses, ideologies and representations of vaccination critics by the media. This part is important, as it enables readers to learn about vaccination policies and practices and helps them understand why there are such fierce battles between the supporters and opponents of vaccination.

The second part, which focuses on ideological constructs of vaccination, represents the main body of the book, where the most common claims about vaccination are systematically analyzed. It presents, among other things, certain mechanisms through which vaccines influence an organism (e.g. damage the nervous system and the immune system). All claims are systematically supported by references to scientific articles, government documents and official statistics.

The decision whether to vaccinate their children or not is one of the most important decisions parents make in connection to their children’s health and life. Therefore, it should never be taken in haste, without consideration, but rather after a thorough examination of the issue. The book Ideological Constructs of Vaccination can help you with that decision. Read it BEFORE your next vaccination appointment.

What others said about the book:

Dr. Stephanie Seneff, a Senior Research Scientist at the MIT

“This book is proof that the anti-vax movement is science-based! This new book is a masterpiece that presents detailed scientific arguments for why vaccines are not the panacea that they are claimed to be. It is a much welcomed addition to the growing body of literature revealing the damage the vaccination program is doing to our children. It is particularly effective in its portrayal of the ideological constructs that are used without basis to defend vaccines and keep the general population uninformed of the reality in terms of risk/benefit tradeoffs. The arguments are well supported by an extensive bibliography. You should buy extra copies of this book ready to hand out to any of your friends who claim that there’s no science behind the anti-vaccine movement!”

Dr. Jayne LM Donegan, MBBS DRCOG DCH DFFP MRCGP MFHom

“It is a minutely researched, scholarly and very readable piece of work that will not disappoint the most thorough researcher or parent who is wanting to have the multiple topics and references to do with vaccination and health policy in one logically ordered resource. For anyone wanting to have a comprehensive, one volume, reference work to read about every aspect of vaccination science and policy, this is the one to get. I cannot recommend it too highly. Buy it and read it. You will be pleased that you did.”

More on: https://www.amazon.com/Ideological-constructs-vaccination-Mateja-Cernic/dp/1909736104


Footnotes

[1] Since practically all vaccine studies (those used in the process of granting a marketing authorization and those published in scientific publications) have more or less the same methodological design and since we are talking about fundamental methodological flaws (especially when it comes to safety studies) this is the only rational explanation. And let me be perfectly clear about this: I do not think and I am not implying that researchers conducting these studies don’t have enough expert knowledge, that they don’t know how to conduct a proper study. On the contrary, they are masters of their trade, possessing vast knowledge about the subject. And it is precisely this knowledge that allows them to design studies portraying entirely false and misleading vaccine profiles without actually falsifying anything. People usually fail to understand or at least fail to appreciate that the same knowledge that allows one to conduct an impeccable, high-quality and rigorous study, also allows one to conduct a study that produces false results without any actual falsification involved. This holds true for all scientific disciplines, from sociology to medicine. And is one of the biggest and most overlooked problems of modern science.

[2] Generally, I am strongly against animal studies. Often they are nothing more than torture of helpless animals without any real value. But, unfortunately, in some instances, animal studies are necessary – researching pharmaceuticals, truly researching them, is often such a case.

[3] Three generations are minimum, and five generations should be sufficient. For more information about this, dive into the field of epigenetics.

[4] It is true that usable examinations, like for example magnetic resonance imaging (MRI), are far too invasive and damaging in their own right to be done on study population, especially frequently. There is no good solution to this problem (methodologically adequate animal studies are probably the best compromise). However, at least blood samples could be taken regularly (one of the things to look for are signs of inflammation) and some minimally invasive testing could/should be used at least on those children who exhibit symptoms of neurological injuries (unusual, high-pitched cry is one such symptom).

[5] In 1980, 32% of biomedical research in the United States was financed by the industry, and in 2000, it was 62%. Currently, most trials are industry sponsored, both in the EU and in the United States (Gøtzsche 2013, p. 57).

[6] Advisory Committee on Immunization Practices (ACIP) has published a list of “conditions incorrectly perceived as contraindications to vaccination (i.e., vaccines may be given under these conditions)”, which includes conditions such as stable neurologic conditions (e.g., cerebral palsy, well-controlled seizures, or developmental delay), autoimmune disease (e.g., systemic lupus erythematosus or rheumatoid arthritis), immunosuppression, etc. (ACIP, https://www.cdc.gov/vaccines/hcp/acip-recs/general-recs/contraindications.html#modalIdString_CDCTable_1; page last updated 12 July 2017).

[7] One of the (obvious) conditions that would have to be met is choosing the appropriate animal species, whose susceptibility to certain disease is similar to that of humans. Another condition that should be strictly met is using only those species that do not produce their own vitamin C. High enough doses of vitamin C can cure and clear almost every infection and significantly contribute to the chance of not developing it in the first place (for more about vitamin C, see Levy, 2011).

Disclaimer: This article is not intended to provide medical advice, diagnosis or treatment. Views expressed here do not necessarily reflect those of GreenMedInfo or its staff.

Blind Spot on Lyme Disease

https://www.thechronicleherald.ca/opinion/opinion-blind-spot-on-lyme-disease-243706/

OPINION: Blind spot on Lyme disease

Holly McKay

Published: Sep 21

Re: “N.S. health system has a handle on Lyme.” I have never written to a newspaper in my life, but after reading provincial chief medical officer Dr. Robert Strang’s Sept. 18 opinion piece, I have no choice but to speak up.

I was so completely horrified by his lack of understanding — and the lack of understanding within the conventional medical community — about what’s going on in the world of Lyme disease. Although, quite frankly, I am used to being horrified, because over the past 10 years, I have been subjected to the provincial health-care system’s utter lack of compassion, understanding and knowledge about the signs and symptoms and effective treatment of chronic Lyme disease.

I have been all over the world at this point, learning about Lyme and how to heal. I am involved in worldwide groups of patients, doctors, virologists, bacteriologists, and other specialists who have devoted their lives to studying chronic illness, Lyme, chronic fatigue syndrome, and the like, and I can assure you, as far as our provincial medical health care goes, we are being failed, plain and simple.

We are being failed when it comes to chronic illness because it is quite simply not our territory, and it is time to drop the facade. The system should step back into its place as an emergency care provider and stop pretending it knows anything about actual health and healing, let alone disease prevention.

Dr. Strang is fantastic at damage control and we are all very grateful for that, but understanding how to truly heal, and what is meant by that, is not his realm. The only thing preventing the medical system from admitting to that is the massive egos of people who feel their identity as some kind of authority on health would be threatened. Well it is, and you’d better get used to it. It’s OK to admit you’ve been wrong, and you’ll be respected beyond your expectations if you do.

Ten years, Dr. Strang. Ten years of watching my life fall apart while receiving nothing but dismissal, ignorance, and quite frankly, abuse in some cases, on the part of my general practitioner, the infectious diseases department as well as the emergency departments of the QEII, the Cobequid Centre and the Colchester-East Hants Health Centre.

I do not use the word “abuse” lightly, either. It is not a word to be thrown around unless you’ve been on the receiving end of it. I assure you, I know it first hand. I, among these hundreds of others — probably thousands — was told to see a psychiatrist; I was told it was all in my head.

An emergency doctor completely dismissed my request for a blood test or to have my blood pressure checked — it felt very low — after I was in seizures for hours. I was passing in and out of consciousness. I was told he was unable to help (or even take me seriously) because I’d taken a bag full of nutritional supplements out of desperation to heal myself because no one was helping me.

My experience with the doctor in the infectious diseases department was the icing on the cake from hell. He refused to face me or even look at me — not once! — as I sat there in my wheelchair explaining all my symptoms. When he spoke, he looked at my husband and addressed him directly using my name. It was absolutely absurd and completely confusing to both my husband and me. I have never encountered such ignorance from a supposed expert in my life.

Not only that, but the only blood test he had ordered was to check cortisol levels, and he forgot to get the results, so wrote it off as “probably unnecessary anyway.” He then told me (to my husband’s face) that he didn’t know what was wrong, but I’d probably never get better, so I’d better get used to it and get myself a therapist to deal with it.

I truly wish I had recorded this interaction, as truth is stranger than fiction. I was so astounded, in fact, that at the time, all I could do was laugh. I didn’t even get angry. But looking back, I am furious. This kind of behaviour — this lack of understanding and compassion — is mind-boggling to see coming from anyone, let alone from someone who works in health care.

Surely he knows our region has a Lyme epidemic, yet he’s completely uneducated about the symptoms? In fact, he said, “Unfortunately, we don’t do diagnostics on symptoms alone.” So it wouldn’t matter if he suspected Lyme or not; he was unwilling to even try to get to the bottom of it.

So I was forced to research alone, to figure this out on my own. Do you have any idea how difficult it is to study and research what is happening to you while your eyeballs are vibrating and your whole body is buzzing like you’re plugged into an electric socket while running on about three hours of sleep a week due to catastrophic insomnia? My body’s normal functions were completely shutting down. You don’t want to imagine, because you can’t. It’s a living nightmare that never seems to end. Relief is so rare that each day is a fight to want to live.

Year after year, I continued to go to my doctor, asking to be referred to someone who could help me. Not a single person even attempted to make sense of what was happening to me or even actually listen, truly listen, to what I was saying. I was just another sack of meat to them. My family doctor just continued to shrug her shoulders and offered very little to no interest in what what going on. In fact, it was always a fight with her to recognize the seriousness of what was happening. She wrote it off several times as psychological and pleaded with me at one point to just try antidepressants.

Finally, one day, I walked into naturopath Bryan Rade’s office, and within five minutes of explaining my symptoms, I was told I probably have Lyme. I went back to the hospital and demanded to be tested for Lyme through conventional testing here in Nova Scotia. The tests came back negative. I went back to the naturopath and had a rigorous procedure to elicit body fluids which were sent to be tested in Boulder, Colo., where they were analyzed. They came back positive.

I immediately went on a protocol for healing Lyme naturally from the information I had gathered on my own, combined with the naturopath’s recommendations. The healing was immediate. Within three months, I felt almost normal again. I’m out of the wheelchair, and I am now beginning to live my life again.

What an incredible relief it was to speak to a doctor who was compassionate, who understood my plight and who had 100 per cent confidence that I would be healed. What a contrast it was to my experience with the provincial health-care system. We are simply not equipped to deal with the epidemic that is happening here. I could go into what Lyme actually is, but they wouldn’t listen anyway. That has been made clear through my days dealing with this.

Conventional medicine is not only ill-equipped, it’s not interested in the truth because it conflicts with the establishment’s need to hold power and be the all-knowing source of information on health. But patching people up is not health care. I apologize for the choice of words, as it clearly does not do justice to the incredible amount of work and knowledge that goes into that “patching up” process.

But health is achieved from the ground up; it’s a holistic process of getting to the bottom of things through a broad, peripheral investigation. Conventional medicine works from the surface down in a narrow and focused fashion, ignoring signs that point to true causes. That’s fine; that’s their job — but can we please admit to that? Please? For the sake of our increasingly sick society?

I really think we need to recognize what we don’t know. Saying that our provincial health-care system’s Lyme testing is accurate is not true in my experience. It doesn’t mean that testing in the U.S. is accurate or not; it simply means that ours is not, and it will save a hell of a lot of pain and suffering going forward if we can just admit to that.

Holly McKay lives in Elmsdale.

_________________

In response to Holly’s article, which has been the experience of thousands of Lyme/MSIDS patients, the following was given:

https://www.thechronicleherald.ca/opinion/voice-of-the-people-sept-29-2018-245728/#.W7nqszjmgx0.linkedin

VOICE OF THE PEOPLE: Sept. 29, 2018
The Chronicle Herald
Published: Sep 29 at 6 a.m.

Heroic women
I am responding specifically to Holly McKay’s opinion piece, “Blind spot on Lyme disease” (Sept. 22), about what she endured with her Lyme dilemma and how our small-minded medical community ignored her many cries for help. It appears our doctors either don’t have the time to listen, as they’re understandably busy, or are indifferent to this real-life condition.

I see a correlation here, too, when I read of Melissa Boutilier’s experience (“U.S. Lyme treatment works,” Sept. 11 letter). Not only had she endured similar responses from her respective doctors, including specialists, about the prescribing of sleeping pills and/or antidepressants, she was also informing all those folks at that time who need a cure that there was indeed one farther away in the U.S. available with the ILADS treatment and heartily recommended it despite what our chief medical officer, Dr. Robert Strang, was telling us.

One woman, Lisa Learning-Ali in Mahone Bay, took it into her hands literally by creating a spray against these ticks when her two sons were finally diagnosed with Lyme disease. Given these kinds of earnest and detailed accountings, to say nothing about the torment of some, why aren’t we taking these women seriously? Is it because our medical system places this condition, along with with mental health issues, into something under a header titled “Collateral Damage,” or, as much it pains me to say, is it because they’re just women?

Well, whatever it is, these brave and intelligent women are my heroes and most Nova Scotians are indebted to them for sharing their stories.

Cliff Williams, Windsor

Open-minded inquiry
Re: “Nova Scotia’s health system has a handle on Lyme” (Sept. 18 opinion piece by Nova Scotia chief medical officer Dr. Robert Strang).

Revered Canadian physician, Sir William Osler, pioneer of modern medical education, was famous for the aphorism: “Listen to the patient long enough, and they will tell you what is wrong with them.”

It is time for physicians, legislators and health officials to do just that. Whereas it took medical science some 500 years to gain a good understanding of syphilis, we are but 40 years into Lyme disease. The Lyme spirochete, Borrelia burgdorferi, is far more genetically complex than even Treponema pallidum, the wily agent of syphilis.

The limitations of currently recommended antibody testing methods and the reality of the persistence of the Lyme bacteria despite antibiotic treatment must be acknowledged. The pursuit of scientific answers to these problems requires allocation of adequate financial and intellectual resources and open-minded inquiry in a spirit of goodwill and co-operation.

Kenneth B. Liegner, M.D., Pawling, N.Y.